Recently, Milan and colleagues [11] revealed the involvement of EZH2 in Wnt/β-catenin signaling pathway activation, which has been shown to be associated with oral cancer progression and chemoresistance. Here, EZH2 is linked to lip and oral cavity carcinoma.